Yehonatan Levin

Yehonatan Levin

Auto-generated profile, based on publicly available information

Yehonatan Levin

Racah Institute of Physics, The Hebrew University of Jerusalem, Jerusalem, Israel

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2024 in Science Advances
Verified
Journal Article
Open access
JSJasmin Sawaed
Jasmin Sawaed
LZLilach Zelik
Lilach Zelik
YLYehonatan Levin
Yehonatan Levin
RFRachel Feeney
Rachel Feeney
MNMaria Naama
Maria Naama
SBShai Bel
Shai Bel
Antibiotic use is a risk factor for development of inflammatory bowel diseases (IBDs). IBDs are characterized by a damaged mucus layer, which does not separate the intestinal epithelium from the microbiota. Here, we hypothesized that antibiotics affect the integrity of the mucus barrier, which allows bacterial penetrance and predisposes to intestinal inflammation. We found that antibiotic treatment led to breakdown of the colonic mucus barrier and penetration of bacteria into the mucus layer. Using fecal microbiota transplant, RNA sequencing followed by machine learning, ex vivo mucus secretion measurements, and antibiotic treatment of germ-free mice, we determined that antibiotics induce endoplasmic reticulum stress in the colon that inhibits colonic mucus secretion in a microbiota-independent manner. This antibiotic-induced mucus secretion flaw led to penetration of bacteria into the colonic mucus layer, translocation of microbial antigens into circulation, and exacerbation of ulcerations in a mouse model of IBD. Thus, antibiotic use might predispose to intestinal inflammation by impeding mucus production.

19 October 2026 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
LZLilach Zelik
Lilach Zelik
YLYehonatan Levin
Yehonatan Levin
JSJasmin Sawaed
Jasmin Sawaed
STShahar Telpaz
Shahar Telpaz
MZMor Zigdon
Mor Zigdon
SBShai Bel
Shai Bel
Antibiotics are believed to affect host physiology by altering the gut microbiota. However, it remains unclear which effects of antibiotics are microbiota dependent and which are microbiota independent. Here we present a resource encompassing host and microbiota responses to antibiotic treatment and a computational tool with which to analyse them. Metagenomic and transcriptomic analyses of conventional and germ-free mice revealed that antibiotic administration routes and their combinations affect host and microbiota responses. We developed CompoRes—a computational tool that distinguishes the microbiota-independent impact of antibiotic-induced perturbations, revealing that antibiotics directly impact host physiology. We found that diurnal expression of major histocompatibility complex class II in the mouse colon is controlled by glucose via feeding. This pattern was lost during antibiotic treatment as vancomycin altered feeding behaviour in a microbiota-independent and evolutionarily conserved manner. Together, our study establishes a direct, non-microbial pathway by which antibiotics reshape host immunity and circadian physiology.